UnitedHealth Group, a leading health insurer, has shared a business update ahead of its upcoming earnings report on Jan. 12. The company's stock has been edging higher in anticipation of this event.
Selling Operations in Brazil
In a securities filing issued on Friday, UnitedHealth Group revealed that it has entered into an agreement to sell its operations in Brazil to a private investor. The sale is expected to be finalized in the first half of next year and is projected to result in a charge of approximately $7 billion. While the exact impact on the company's 2024 net earnings outlook was not disclosed, it is a significant development for UnitedHealth Group.
Impact on Earnings Outlook
Despite the impending sale in Brazil, UnitedHealth Group confirmed that its adjusted earnings guidance for 2024 will remain unchanged. The numbers originally shared at the company's investor conference on Nov. 29 indicated a projected range of adjusted net earnings between $27.50 and $28 per share.
Market Response and Stock Performance
Following the business update, UnitedHealth Group's stock experienced a slight increase of 0.2% during Friday's trading session, reaching $526 per share. It is worth noting that the company's stock performance for this year has remained relatively steady, resulting in minimal overall fluctuations.
We will continue to monitor UnitedHealth Group's progress and provide updates as more information becomes available.